Actual Five-year Survival After Upfront Resection for Pancreatic Ductal Adenocarcinoma

To determine actual five-year survival (5YS) rates associated with a strategy of upfront surgery and adjuvant therapy in pancreatic ductal adenocarcinoma (PDAC).The rate of actual 5YS in PDAC remains controversial. Available data is restricted to cohorts acquired over several decades and series of resection after patient selection by neoadjuvant therapy.All patients undergoing upfront resection for resectable and borderline-resectable PDAC from...